A meta-analysis of the efficacy of programmed cell death 1/its ligand inhibitors plus cytotoxic T-lymphocyte-associated antigen 4 inhibitors in non-small cell lung cancer

A meta-analysis of the efficacy of programmed cell death 1/its ligand inhibitors plus cytotoxic T-lymphocyte-associated antigen 4 inhibitors in non-small cell lung cancer

Background: Immune checkpoint inhibitors (ICIs), either as monotherapy or in combination with chemotherapy, have improved the therapeutic outcome for non-small cell lung cancer (NSCLC). However, the efficacy of combination therapies, such as programmed cell death 1(PD-1)/its ligand (PD-L1) and cytot...

Full description

Bibliographic Details
Main Authors: Li Lin, Lu Xiao, Lei Li, Chen Chen, Haorong Zhang, Changyan Yu, Lanfang Zhang, Anhua Wei, Wei Li
Format: Article
Language:English
Published: Frontiers Media S.A. 2024-02-01
Series:Frontiers in Pharmacology
Subjects:
CTLA-4 inhibitor
PD-1/PD-L1 inhibitor
non-small cell lung cancer
meta-analysis
NSCLC
Online Access:https://www.frontiersin.org/articles/10.3389/fphar.2024.1267763/full

Internet

https://www.frontiersin.org/articles/10.3389/fphar.2024.1267763/full

Similar Items